Impact of Immune Checkpoint Inhibitors on Care of Patients with Advanced Bladder Cancer

Impact of Immune Checkpoint Inhibitors on Care of Patients with Advanced Bladder Cancer

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023Подробнее

Immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: ASCO GU 2023

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MDПодробнее

Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD

How is Advanced Bladder Cancer Treated?Подробнее

How is Advanced Bladder Cancer Treated?

Therapeutic Advances in Patient Care for Early to Advanced Bladder CancerПодробнее

Therapeutic Advances in Patient Care for Early to Advanced Bladder Cancer

The evolving role of antibody-drug conjugates in the treatment of urothelial carcinomaПодробнее

The evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma

Immunotherapeutics with Dr. James GulleyПодробнее

Immunotherapeutics with Dr. James Gulley

2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder CancerПодробнее

2.22.2021 Urology COViD Didactics - Immunotherapy for Bladder Cancer

Beyond Checkpoint Blockade for Cancer ImmunotherapyПодробнее

Beyond Checkpoint Blockade for Cancer Immunotherapy

Immune Checkpoint Blockade: A New Era in Cancer TreatmentПодробнее

Immune Checkpoint Blockade: A New Era in Cancer Treatment

Актуальное